• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高对神经性厌食症男性患者的理解、识别与治疗水平。

Improving Understanding, Recognition and Treatment for Men With Anorexia Nervosa.

作者信息

Downs James, Kelly Clive

机构信息

King's College London, London, UK.

Department of Rheumatology, James Cook University Hospital, Middlesbrough, UK.

出版信息

Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-15. doi: 10.12968/hmed.2024.0643. Epub 2025 Jun 5.

DOI:10.12968/hmed.2024.0643
PMID:40554450
Abstract

Anorexia Nervosa (AN) in males is often overlooked due to the traditional perception of eating disorders as female concerns. Despite this, there has been an increased focus on male presentations. Research evidence, including concerns from people with lived experience, highlights specific risks and unmet clinical needs as a result of delayed help-seeking, inaccessible services, and treatment that does not account for men's needs. Published research and personal narrative from an author with lived experience are combined to assess (1) existing evidence and gaps in knowledge and treatment for males with AN, and (2) solutions which may address challenges across research, policy, and clinical practice. There is an increased prevalence of AN amongst males, with most recent data from National Health Service (NHS) England showing a faster increase in hospitalisations amongst males compared with females. However, the quantity and quality of prevalence data and research into the drivers of this trend are severely lacking. The exclusion of males from clinical research has hindered efforts to assess the efficacy of current AN treatments, despite emerging evidence for males-specific symptoms and health impacts across biopsychosocial domains. These include more frequent use of excessive exercise, feelings of emasculation, neurodivergence, and specific physiological risks occurring at higher weights than females. These factors combine with under-resourced treatment provision which often feels exclusionary to males to create an increased risk of death and significant barriers to recovery. Evidenced solutions for providing more timely recognition and effective treatment for males with AN are limited, emphasising the importance of further research. Present-day clinical practice needs to ensure the safe medical management of males with AN, taking an integrated approach to treatment that accounts for co-occurring conditions and minority status identities. Being more responsive to the needs of males with AN and removing the barriers to effective care can be aided by projects that collaborate with men with lived experience.

摘要

由于传统观念认为饮食失调是女性才有的问题,男性神经性厌食症(AN)常常被忽视。尽管如此,男性患者的情况越来越受到关注。包括有实际患病经历者所表达的担忧在内的研究证据表明,由于寻求帮助延迟、服务难以获得以及治疗未考虑男性需求,导致了特定风险和未满足的临床需求。本文结合已发表的研究和一位有实际患病经历的作者的个人叙述,来评估:(1)关于男性神经性厌食症患者现有证据以及知识和治疗方面的差距;(2)可能解决研究、政策和临床实践中各种挑战的方案。男性神经性厌食症的患病率呈上升趋势,英国国家医疗服务体系(NHS)的最新数据显示,男性住院人数的增长速度快于女性。然而,患病率数据的数量和质量以及对这一趋势驱动因素的研究严重不足。尽管有新证据表明男性存在特定症状以及在生物心理社会各领域对健康有影响,但男性被排除在临床研究之外,这阻碍了评估当前神经性厌食症治疗效果的努力。这些影响包括更频繁地过度运动、有 emasculation(该词可能有误,推测是“男性特质缺失感”之类意思,因原词不太准确暂保留)的感觉、神经差异以及在体重高于女性时出现的特定生理风险。这些因素与资源不足的治疗服务相结合,而这些服务往往让男性感觉被排斥,从而增加了死亡风险和康复的重大障碍。为男性神经性厌食症患者提供更及时识别和有效治疗的经证实的解决方案有限,这凸显了进一步研究的重要性。当今的临床实践需要确保对男性神经性厌食症患者进行安全的医疗管理,采用综合治疗方法,考虑到并发疾病和少数群体身份。与有实际患病经历的男性合作的项目有助于更积极地响应男性神经性厌食症患者的需求并消除有效护理的障碍。

相似文献

1
Improving Understanding, Recognition and Treatment for Men With Anorexia Nervosa.提高对神经性厌食症男性患者的理解、识别与治疗水平。
Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-15. doi: 10.12968/hmed.2024.0643. Epub 2025 Jun 5.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Psychometric properties of the Chinese version of the pros and cons of anorexia nervosa (P-CAN-C) scale: a validation study in patients with anorexia nervosa.神经性厌食症利弊中文版量表(P-CAN-C)的心理测量学特性:一项针对神经性厌食症患者的效度研究
J Eat Disord. 2025 Jun 16;13(1):111. doi: 10.1186/s40337-025-01314-x.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.